ES2175453T3 - Procedimiento de diagnostico para la alterosclerosis. - Google Patents

Procedimiento de diagnostico para la alterosclerosis.

Info

Publication number
ES2175453T3
ES2175453T3 ES97939603T ES97939603T ES2175453T3 ES 2175453 T3 ES2175453 T3 ES 2175453T3 ES 97939603 T ES97939603 T ES 97939603T ES 97939603 T ES97939603 T ES 97939603T ES 2175453 T3 ES2175453 T3 ES 2175453T3
Authority
ES
Spain
Prior art keywords
diagnostic procedure
alterosclerosis
sample
undertained
phagocits
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97939603T
Other languages
English (en)
Inventor
Jay W Heinecke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Application granted granted Critical
Publication of ES2175453T3 publication Critical patent/ES2175453T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/323—Arteriosclerosis, Stenosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Hydrogenated Pyridines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measurement Of Mechanical Vibrations Or Ultrasonic Waves (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

SE DESCRIBEN UN PROCEDIMIENTO DIAGNOSTICO Y UNA PRUEBA DE DETERMINACION DE LA ATEROSCLEROSIS Y ENFERMEDADES ANALOGAS QUE ESTAN RELACIONADAS CON LA ACTIVACION DE FAGOCITOS Y/O INFLAMACION, QUE COMPRENDE DETERMINAR LA PRESENCIA DE 3 - CLOROTIROSINA EN UNA MUESTRA DE ENSAYO DE UN FLUIDO O TEJIDO CORPORAL, A UN NIVEL ELEVADO CON RELACION AL NIVEL EXISTENTE EN UN PACIENTE NORMAL.
ES97939603T 1996-09-09 1997-09-03 Procedimiento de diagnostico para la alterosclerosis. Expired - Lifetime ES2175453T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/709,916 US6268220B1 (en) 1996-09-09 1996-09-09 Diagnostic method for atherosclerosis

Publications (1)

Publication Number Publication Date
ES2175453T3 true ES2175453T3 (es) 2002-11-16

Family

ID=24851820

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97939603T Expired - Lifetime ES2175453T3 (es) 1996-09-09 1997-09-03 Procedimiento de diagnostico para la alterosclerosis.

Country Status (11)

Country Link
US (1) US6268220B1 (es)
EP (1) EP0931264B1 (es)
JP (1) JP3553611B2 (es)
AT (1) ATE216495T1 (es)
AU (1) AU4165197A (es)
CA (1) CA2264757C (es)
DE (1) DE69712079T2 (es)
DK (1) DK0931264T3 (es)
ES (1) ES2175453T3 (es)
PT (1) PT931264E (es)
WO (1) WO1998010294A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306576B1 (en) 1999-02-19 2001-10-23 Cleveland Clinic Foundation Diagnostic methods for asthma
US6548252B1 (en) * 2000-10-13 2003-04-15 Esa, Inc. Detection of DNA damage
US7780950B2 (en) * 2002-01-02 2010-08-24 The Cleveland Clinic Foundation Systemic marker for monitoring anti-inflammatory and antioxidant actions of therapeutic agents
WO2002062207A2 (en) * 2001-01-02 2002-08-15 The Cleveland Clinic Foundation Myeloperoxidase, a risk indicator for cardiovascular disease
US20040132123A1 (en) * 2001-05-09 2004-07-08 Oron Yacoby-Zeevi Methods and kits utilizing heparanase as a diagnostic marker for haemostatic disorders
US6939716B2 (en) * 2001-09-19 2005-09-06 Washington University Method for detecting conditions indicative of sepsis
US20060166295A1 (en) * 2002-07-01 2006-07-27 James Woods Method for determination of likelihood of occurrence of preterm labor in pregnant females
US7459286B1 (en) * 2003-10-22 2008-12-02 The Cleveland Clinic Foundation Assessing the risk of a major adverse cardiac event in patients with chest pain
ES2381551T3 (es) 2003-12-05 2012-05-29 The Cleveland Clinic Foundation Marcadores de riesgo para enfermedad cardiovascular
WO2006014628A1 (en) * 2004-07-19 2006-02-09 University Of Washington Methods for assessing the risk for development of cardiovascular disease
US7378396B2 (en) 2004-08-11 2008-05-27 The Cleveland Clinic Foundation Therapeutic agents and methods for cardiovascular disease
DE102004042530B4 (de) * 2004-09-02 2006-10-19 Mosaiques Diagnostics And Therapeutics Ag Verfahren zur Diagnose von Arteriosklerose
US8241861B1 (en) 2008-07-08 2012-08-14 Insilicos, Llc Methods and compositions for diagnosis or prognosis of cardiovascular disease
JP2013541560A (ja) * 2010-10-19 2013-11-14 バテル・メモリアル・インスティテュート 組成物、抗体、喘息診断方法、及び抗体の調製方法
US9606082B2 (en) 2015-05-11 2017-03-28 The University Of North Carolina At Chapel Hill Pressure driven microfluidic injection for chemical separations
US10734216B2 (en) 2015-05-11 2020-08-04 The University Of North Carolina At Chapel Hill Pressure driven fluidic injection for chemical separations by electrophoresis
US9728387B2 (en) 2015-10-20 2017-08-08 The University Of North Carolina At Chapel Hill Solid phase extraction with capillary electrophoresis

Also Published As

Publication number Publication date
DE69712079D1 (de) 2002-05-23
CA2264757C (en) 2005-10-04
JP2001500257A (ja) 2001-01-09
EP0931264A1 (en) 1999-07-28
US6268220B1 (en) 2001-07-31
DK0931264T3 (da) 2002-08-05
JP3553611B2 (ja) 2004-08-11
AU4165197A (en) 1998-03-26
ATE216495T1 (de) 2002-05-15
DE69712079T2 (de) 2002-10-02
PT931264E (pt) 2002-08-30
EP0931264B1 (en) 2002-04-17
CA2264757A1 (en) 1998-03-12
WO1998010294A1 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
ES2175453T3 (es) Procedimiento de diagnostico para la alterosclerosis.
ES2176778T3 (es) Metodo de diagnostico para la aterosclerosis.
DK0756708T3 (da) Anvendelse af humant neutrophil-lipocalin (HNL) som en diagnostisk markør og anti-HNL-antistof-præparat
DE69631738D1 (de) Medizinische implantierbare Vorrichtung für elektrochemische Messungen von Bluteigenschaften
DE69736527D1 (de) Messvorrichtung zur schnellen nichtinvasiven blutdruckbestimmung
ES285023U (es) Sonda de dialisis,principalmente prevista para su insercion en tejidos biologicos
ES2152198T1 (es) Localizacion no invasora de un conjugado emisor de luz en mamiferos.
ES2075050T3 (es) Peptidos que tienen actividad cooperadora de celulas t.
DE69632276T2 (de) Oszillometrisches Blutdrucküberwachungsgerät für automatische Blutdruckmessungen
EA200000445A1 (ru) Способы лечения состояния гиперкоагуляции или приобретенной недостаточности белка c
ES2058164T3 (es) Conjugados fluorescentes y ensayo de diagnostico biologico.
BR9708161A (pt) Peptídeos com aumentada afinidade de ligação para moléculas hla
NO901085D0 (no) Fremgangsmaate og innretning for bestemmelse av trykk-diameter-forholdet for en arterie ved hjelp av ikke-invasive foranstaltninger.
DK0749582T3 (da) Fremgangsmåde til diagnosticering af præeklampsi
DE69732223D1 (de) Ultraschall-Echographiesystem zur Untersuchung von Arterien
SE9604815D0 (sv) A metod of diagnosis
ES2103582T5 (es) Ensayo para microvesiculas derivadas de las plaquetas.
ATE304712T1 (de) Thrombozyten-aktivierten vollblutgerinnungszeit
SE9401883L (sv) Sätt vid diagnosticering av födoämnesintolerans/allergi samt instrument för diagnostiseringen
DK0795130T3 (da) Diagnostisk metode ved inflammatoriske tilstande i tarmene
EA199800352A1 (ru) ПОЛИПЕПТИД ХЕМОКИНА β-8 (ВАРИАНТЫ) И СПОСОБ ЕГО ПОЛУЧЕНИЯ, КОМПОЗИЦИИ ПОЛИПЕПТИДОВ, ВЕКТОР, КЛЕТКА-ХОЗЯИН, АГОНИСТ И АНТАГОНИСТ, ВСЕ - УПОМЯНУТОГО ПОЛИПЕПТИДА, И СПОСОБ ИДЕНТИФИКАЦИИ ПОСЛЕДНЕГО, СПОСОБ ЛЕЧЕНИЯ БОЛЬНОГО, ИСПЫТЫВАЮЩЕГО ПОТРЕБНОСТЬ В Хк-β-8 (ВАРИАНТЫ), СПОСОБ ЛЕЧЕНИЯ БОЛЬНОГО, ИСПЫТЫВАЮЩЕГО ПОТРЕБНОСТЬ В ПОДАВЛЕНИИ Хк-β-8, СПОСОБ ДИАГНОСТИКИ ЗАБОЛЕВАНИЯ ИЛИ ПРЕДРАСПОЛОЖЕННОСТИ К ЗАБОЛЕВАНИЮ, ОБУСЛОВЛЕННОМУ НЕДОСТАТОЧНОЙ ЭКСПРЕССИЕЙ ПОЛИПЕПТИДА
FI974424A7 (fi) Varhainen diagnostinen testi
DK0745221T3 (da) Pyridinolin krydsbindinger som markører for periodontal og peri-implantat og sygdomsaktivitet
DE69815661D1 (de) Diagnostische verfahren und zusammensetzungen auf basis der verteilung von rad51
ATE251309T1 (de) Verfahren zur bestimmung eines erhöhten sterblichkeitsrate

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 931264

Country of ref document: ES